In vitro studies on the roles of transforming growth factor-beta 1 in rat metanephric development

A T Clark1, R J Young, J F Bertram

  • 1Department of Pathology, Baylor College of Medicine, Houston, Texas, USA.

Kidney International
|April 25, 2001
PubMed
Abstract

Insights

Transforming growth factor-beta1 (TGF-beta 1) inhibits ureteric duct growth, reducing nephron endowment in developing kidneys. However, TGF-beta 1 does not significantly impact nephron development after initial formation.

Area of Science:

  • Developmental biology
  • Renal physiology
  • Molecular signaling

Background:

  • Kidney development involves complex molecular regulation.
  • Transforming growth factor-beta1 (TGF-beta 1) is known to inhibit ureteric duct growth.
  • The role of TGF-beta 1 in nephron development and glomerulogenesis is understudied.

Purpose of the Study:

  • To investigate the localization of TGF-beta 1 and its receptor in developing rat kidneys.
  • To determine the effect of exogenous TGF-beta 1 on ureteric duct growth and nephron development in vitro.

Main Methods:

  • In situ hybridization and RT-PCR to detect TGF-beta 1 and ALK-5 mRNA.
  • Rat metanephric organ culture with exogenous TGF-beta 1 administration at various time points.

Main Results:

  • TGF-beta 1 mRNA localized with the TGF-beta type II receptor, not ALK-5.
  • Exogenous TGF-beta 1 inhibited ureteric tree growth and nephron number.
  • TGF-beta 1 promoted renal capsule hypertrophy when added early in culture.

Conclusions:

  • TGF-beta 1 inhibits ureteric duct growth, impacting nephron endowment in developing kidneys.
  • TGF-beta 1 does not appear critical for nephron development post-epithelial vesicle formation.